US 11512112
Peptide for suppressing osteoclast differentiation and use thereof
granted A61KA61K38/00A61K38/04
Quick answer
US patent 11512112 (Peptide for suppressing osteoclast differentiation and use thereof) held by CAREGEN CO., LTD. expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CAREGEN CO., LTD.
- Grant date
- Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K38/00, A61K38/04, A61K38/10, A61P